Medtronic spine revenue up nearly 1% to $658M; robotics grows while spinal cord stimulation slows: 5 details

Laura Dyrda -   Print  |

Medtronic reported 1.5 percent revenue increase in the first quarter of the 2020 fiscal year, hitting $7.5 billion. 


Five things to know:

1. Medtronic's spine line reported a 0.9 percent revenue increase to $658 million for the first quarter. When combined with Medtronic's spine and enabling technologies sales — which includes spinal robotics and navigation — global spine and U.S. core spine revenues grew in the mid-single digits.

2. Cervical spine sales were up in the mid-single digits, largely attributed to the Infinity OCT system launch and growth of Prestige LP cervical disc use.

3. Medtronic reported Infuse sales were up in the low double-digits for the quarter, on a constant currency basis.

4. The brain therapies sales, which include the neurosurgery business, reported 9.8 percent revenue growth to $740 million. Double-digit growth of StealthStation S8 surgical navigation systems, O-arm surgical imaging systems and Mazor X robotic guidance system drove the neurosurgery business.

5. Medtronic also reported a 7 percent decrease in pain therapies revenue for the first quarter, which hit $292 million. The company attributed channel destocking and a slowdown in the spinal cord stimulation market for the segment's poor performance.

More articles on spine devices:
Dr. Abdul Baker performs robotic-assisted spinal surgery at Sanford hospital
Who had the best Q2? How 12 spine, orthopedic companies performed
4 recent spine, orthopedic device company mergers & acquisitions

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers